International trade · 23/07/2026Updated: 10/17/2026 · 1 min read
USPTO Grants Interim Extension to Centanafadine Hydrochloride Patent
Summary
The United States Patent and Trademark Office has issued an order granting a one-year extension to the term of U.S. Patent No. 9,737,506, allowing Centanafadine Hydrochloride to maintain its patent protection for an additional year.